التفاصيل البيبلوغرافية
| العنوان: |
Quantification of 1,3‐β‐d‐glucan by Wako β‐glucan assay for rapid exclusion of invasive fungal infections in critical patients: A diagnostic test accuracy study. |
| المؤلفون: |
Cento, Valeria, Alteri, Claudia, Mancini, Valentina, Gatti, Milo, Lepera, Valentina, Mazza, Ernestina, Moioli, Maria Cristina, Merli, Marco, Colombo, Jacopo, Orcese, Carlo Andrea, Bielli, Alessandra, Torri, Stefania, Gasparini, Laura Elisa, Vismara, Chiara, De Gasperi, Andrea, Brioschi, Paolo, Puoti, Massimo, Cairoli, Roberto, Lombardi, Gianluigi, Perno, Carlo Federico |
| المصدر: |
Mycoses; Dec2020, Vol. 63 Issue 12, p1299-1310, 12p |
| مصطلحات موضوعية: |
MYCOSES, DIAGNOSIS methods, INTENSIVE care units, INVASIVE candidiasis, SYMPTOMS |
| مستخلص: |
Summary: Objectives: Rapid and reliable exclusion of invasive fungal infections (IFI) by markers able to avoid unnecessary empirical antifungal treatment is still a critical unmet clinical need. We investigated the diagnostic performance of a newly available β‐d‐Glucan (BDG) quantification assay, focusing on the optimisation of the BDG cut‐off values for IFI exclusion. Methods: BDG results by Wako β‐glucan assay (lower limit of detection [LLOD] = 2.16 pg/mL, positivity ≥ 11 pg/mL) on two consecutive serum samples were retrospectively analysed in 170 patients, admitted to haematological wards (N = 42), intensive care units (ICUs; N = 80), or other wards (N = 48), exhibiting clinical signs and/or symptoms suspected for IFI. Only patients with proven IFI (EORTC/MSG criteria) were considered as true positives in the assessment of BDG sensitivity, specificity and predictive values. Results: Patients were diagnosed with no IFI (69.4%), proven IFI (25.3%) or probable IFI (5.3%). Two consecutive BDG values < LLOD performed within a median of 1 (interquartile range: 1‐3) day were able to exclude a proven IFI with 100% sensitivity and negative predictive value (primary study goal). Test's specificity improved by using two distinct positivity and negativity cut‐offs (7.7 pg/mL and LLOD, respectively), but remained suboptimal in ICU patients (50%), as compared to haematological or other patients (93% and 90%, respectively). Conclusions: The classification of Wako's results as negative when < LLOD, and positive when > 7.7 pg/mL, could be a promising diagnostic approach to confidently rule out an IFI in both ICU and non‐ICU patients. The poor specificity in the ICU setting remains a concern, due to the difficulty to interpret positive results in this fragile population. [ABSTRACT FROM AUTHOR] |
|
Copyright of Mycoses is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
Full Text Finder